糖尿病对闭塞性血管死亡风险的性别特异性关联:98万人协作荟萃分析
该协作荟萃分析纳入68项前瞻性研究、980 793名成人的个体数据,随访9·8百万人年。校正主要血管危险因素后,糖尿病使男性闭塞性血管死亡风险约翻倍(RR 2·10),女性约增至三倍(RR 3·00),女性相对风险高于男性,但绝对超额风险相近。
要点
- 糖尿病使男性闭塞性血管死亡风险约翻倍(RR 2·10),女性约三倍(RR 3·00)。
- 35–59岁女性糖尿病者闭塞性血管死亡RR最高(5·55),高于同龄男性。
- 糖尿病相关闭塞性血管死亡的绝对超额风险男女相近。
核心结论
- 独立于其他主要血管危险因素,糖尿病显著增加男女闭塞性血管死亡风险。
- 女性糖尿病者的相对风险高于男性,但绝对超额风险相近。
- 女性糖尿病者相对超额风险的原因尚未解释。
研究设计与样本
- 协作荟萃分析,纳入68项前瞻性研究的个体参与者数据。
- 共分析980 793名成人,随访9·8百万人年。
- 采用Cox回归模型评估糖尿病与闭塞性血管死亡的关系。
主要发现
- 随访期间35–89岁参与者中76 965例死亡,其中19 686例(25·6%)归因于闭塞性血管病。
- 校正主要血管危险因素后,糖尿病男性闭塞性血管死亡RR 2·10(95%CI 1·97–2·24),女性RR 3·00(95%CI 2·71–3·33),异质性检验p<0·0001。
- 男女合并后,35–59岁者RR 2·60(95%CI 2·30–2·94),高于70–89岁者RR 2·01(95%CI 1·85–2·19),趋势p=0·0001。
- 35–59岁女性糖尿病者闭塞性血管死亡RR最高(5·55,95%CI 4·15–7·44)。
- 35–59岁糖尿病相关年绝对超额风险女性0·05%(95%CI 0·03–0·07),男性0·08%(95%CI 0·05–0·10);70–89岁女性1·08%(95%CI 0·84–1·32),男性0·91%(95%CI 0·77–1·05)。
关键数值与推荐
- 总胆固醇、血压和BMI与闭塞性血管死亡呈连续对数线性关联,在有无糖尿病及男女间相似。
临床怎么用
- 原文指出,减少吸烟和肥胖的生活方式改变以及针对主要血管风险的成本效益药物(如他汀和降压药)对糖尿病男女均重要。
- 原文指出,上述措施可能不能降低女性糖尿病者闭塞性血管病的相对超额风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several studies have shown that diabetes confers a higher relative risk of vascular mortality among women than among men, but whether this increased relative risk in women exists across age groups and within defined levels of other risk factors is uncertain. We aimed to determine whether differences in established risk factors, such as blood pressure, BMI, smoking, and cholesterol, explain the higher relative risks of vascular mortality among women than among men. METHODS: In our meta-analysis, we obtained individual participant-level data from studies included in the Prospective Studies Collaboration and the Asia Pacific Cohort Studies Collaboration that had obtained baseline information on age, sex, diabetes, total cholesterol, blood pressure, tobacco use, height, and weight. Data on causes of death were obtained from medical death certificates. We used Cox regression models to assess the relevance of diabetes (any type) to occlusive vascular mortality (ischaemic heart disease, ischaemic stroke, or other atherosclerotic deaths) by age, sex, and other major vascular risk factors, and to assess whether the associations of blood pressure, total cholesterol, and body-mass index (BMI) to occlusive vascular mortality are modified by diabetes. RESULTS: Individual participant-level data were analysed from 980 793 adults. During 9·8 million person-years of follow-up, among participants aged between 35 and 89 years, 19 686 (25·6%) of 76 965 deaths were attributed to occlusive vascular disease. After controlling for major vascular risk factors, diabetes roughly doubled occlusive vascular mortality risk among men (death rate ratio [RR] 2·10, 95% CI 1·97-2·24) and tripled risk among women (3·00, 2·71-3·33; χ2 test for heterogeneity p<0·0001). For both sexes combined, the occlusive vascular death RRs were higher in younger individuals (aged 35-59 years: 2·60, 2·30-2·94) than in older individuals (aged 70-89 years: 2·01, 1·85-2·19; p=0·0001 for trend across age groups), and, across age groups, the death RRs were higher among women than among men. Therefore, women aged 35-59 years had the highest death RR across all age and sex groups (5·55, 4·15-7·44). However, since underlying confounder-adjusted occlusive vascular mortality rates at any age were higher in men than in women, the adjusted absolute excess occlusive vascular mortality associated with diabetes was similar for men and women. At ages 35-59 years, the excess absolute risk was 0·05% (95% CI 0·03-0·07) per year in women compared with 0·08% (0·05-0·10) per year in men; the corresponding excess at ages 70-89 years was 1·08% (0·84-1·32) per year in women and 0·91% (0·77-1·05) per year in men. Total cholesterol, blood pressure, and BMI each showed continuous log-linear associations with occlusive vascular mortality that were similar among individuals with and without diabetes across both sexes. INTERPRETATION: Independent of other major vascular risk factors, diabetes substantially increased vascular risk in both men and women. Lifestyle changes to reduce smoking and obesity and use of cost-effective drugs that target major vascular risks (eg, statins and antihypertensive drugs) are important in both men and women with diabetes, but might not reduce the relative excess risk of occlusive vascular disease in women with diabetes, which remains unexplained. FUNDING: UK Medical Research Council, British Heart Foundation, Cancer Research UK, European Union BIOMED programme, and National Institute on Aging (US National Institutes of Health).
引用
- Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol. 2018. PMID: 29752194. doi:10.1016/S2213-8587(18)30079-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。